Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Virginia Borges

Concepts (593)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
150
2026
2380
12.690
 Why?
Pregnancy Complications, Neoplastic
17
2026
63
3.530
 Why?
Postpartum Period
20
2026
372
2.800
 Why?
Cancer Survivors
20
2025
337
2.440
 Why?
Receptors, Estrogen
23
2026
401
2.210
 Why?
Antineoplastic Agents, Hormonal
16
2026
192
2.110
 Why?
Antineoplastic Combined Chemotherapy Protocols
21
2025
1958
1.880
 Why?
Carcinoma, Ductal, Breast
10
2023
89
1.690
 Why?
Mastectomy
17
2024
181
1.570
 Why?
Protein Kinase Inhibitors
7
2025
979
1.400
 Why?
Receptors, Progesterone
10
2026
243
1.250
 Why?
Lactation
9
2021
193
1.230
 Why?
Brain Neoplasms
11
2025
1328
1.210
 Why?
Female
169
2026
78636
1.180
 Why?
Carcinoma, Intraductal, Noninfiltrating
7
2023
61
1.100
 Why?
Neoplasm Metastasis
13
2025
688
1.050
 Why?
Breast
10
2021
156
1.000
 Why?
Adult
103
2026
40665
1.000
 Why?
Triple Negative Breast Neoplasms
7
2025
218
0.940
 Why?
Oxazoles
8
2025
48
0.940
 Why?
Pregnancy
37
2026
7182
0.910
 Why?
Antineoplastic Agents
12
2023
2207
0.910
 Why?
Humans
178
2026
145140
0.880
 Why?
Trastuzumab
13
2023
118
0.880
 Why?
Pyridines
9
2025
608
0.850
 Why?
Quinazolines
8
2025
266
0.840
 Why?
Mammary Glands, Human
7
2020
68
0.830
 Why?
Neoplasm Recurrence, Local
15
2026
1146
0.810
 Why?
Supreme Court Decisions
1
2022
12
0.740
 Why?
Mammary Glands, Animal
9
2021
128
0.700
 Why?
Carcinoma
3
2021
224
0.680
 Why?
BRCA2 Protein
5
2024
68
0.670
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.650
 Why?
Semaphorins
4
2025
37
0.650
 Why?
Fertility Preservation
7
2025
55
0.640
 Why?
Middle Aged
61
2026
36126
0.620
 Why?
Maternal Age
1
2020
127
0.600
 Why?
Breast Feeding
6
2025
446
0.600
 Why?
Prospective Studies
34
2026
8035
0.600
 Why?
Drug Resistance, Neoplasm
3
2022
881
0.600
 Why?
Prognosis
17
2026
4310
0.590
 Why?
Neoplasm Staging
19
2026
1467
0.580
 Why?
Antigens, CD
6
2025
558
0.580
 Why?
Chemotherapy, Adjuvant
16
2026
423
0.580
 Why?
Neoadjuvant Therapy
6
2021
465
0.580
 Why?
Estradiol
5
2019
512
0.560
 Why?
Biomarkers, Tumor
13
2026
1320
0.560
 Why?
Extracellular Vesicles
1
2020
169
0.540
 Why?
Young Adult
38
2026
14176
0.540
 Why?
Carcinoma in Situ
3
2022
44
0.530
 Why?
Parity
7
2022
111
0.530
 Why?
Lymphatic Metastasis
10
2021
331
0.510
 Why?
Neoplasms, Second Primary
3
2024
102
0.500
 Why?
Quality of Life
12
2025
3194
0.490
 Why?
Cyclooxygenase 2
5
2020
166
0.460
 Why?
Mutation
11
2025
4071
0.430
 Why?
Capecitabine
5
2023
56
0.420
 Why?
Melanoma
4
2018
759
0.420
 Why?
Aromatase Inhibitors
6
2019
78
0.410
 Why?
Skin Neoplasms
4
2013
848
0.410
 Why?
Carcinoma, Lobular
2
2012
56
0.410
 Why?
Liver Neoplasms
4
2016
775
0.410
 Why?
Mastectomy, Segmental
6
2022
107
0.410
 Why?
Combined Modality Therapy
10
2023
1264
0.400
 Why?
Puerperal Disorders
2
2014
36
0.390
 Why?
BRCA1 Protein
4
2024
82
0.380
 Why?
Disease-Free Survival
8
2026
766
0.370
 Why?
Stromal Cells
3
2013
120
0.360
 Why?
Tumor Suppressor Protein p53
2
2021
532
0.350
 Why?
Genes, BRCA2
3
2026
33
0.350
 Why?
Genes, BRCA1
3
2026
45
0.340
 Why?
Anxiety
7
2022
1117
0.340
 Why?
Neoplasms
7
2026
2900
0.340
 Why?
Resistance Training
2
2025
186
0.340
 Why?
Nevus, Pigmented
1
2011
35
0.330
 Why?
Sexual Partners
3
2022
193
0.330
 Why?
Epithelial Cells
6
2018
1127
0.330
 Why?
Neoplasm Invasiveness
6
2020
506
0.320
 Why?
Social Support
4
2025
645
0.310
 Why?
Fertility
5
2025
173
0.310
 Why?
Tamoxifen
7
2021
191
0.310
 Why?
Premenopause
6
2026
125
0.310
 Why?
Estrogens
4
2015
367
0.300
 Why?
Cyclophosphamide
5
2020
266
0.300
 Why?
Aged
30
2026
26096
0.300
 Why?
Radiosurgery
3
2021
399
0.300
 Why?
Adjuvants, Immunologic
2
2022
243
0.290
 Why?
Gene Expression Profiling
8
2020
1763
0.290
 Why?
Antibodies, Monoclonal, Humanized
7
2025
992
0.290
 Why?
Thrombophilia
1
2009
89
0.280
 Why?
Risk Factors
17
2024
10857
0.280
 Why?
T-Lymphocytes
6
2018
1993
0.280
 Why?
Cohort Studies
12
2025
5988
0.280
 Why?
Patient Acceptance of Health Care
2
2025
881
0.280
 Why?
GPI-Linked Proteins
4
2025
81
0.280
 Why?
Incidence
7
2024
2915
0.280
 Why?
Cell Line, Tumor
10
2025
3539
0.270
 Why?
Mice
21
2025
18303
0.270
 Why?
Quinolines
3
2025
190
0.270
 Why?
Animals
31
2025
37952
0.270
 Why?
Heterozygote
2
2026
312
0.270
 Why?
Gene Expression Regulation, Neoplastic
4
2021
1442
0.270
 Why?
Breast Neoplasms, Male
2
2018
29
0.260
 Why?
Doxorubicin
5
2020
396
0.260
 Why?
Follow-Up Studies
7
2026
5411
0.260
 Why?
Employment
2
2019
184
0.260
 Why?
Kaplan-Meier Estimate
4
2020
968
0.260
 Why?
Appetite
2
2025
79
0.260
 Why?
Decision Making
4
2022
974
0.250
 Why?
Lymphocytes, Tumor-Infiltrating
2
2026
153
0.250
 Why?
Maytansine
2
2018
18
0.250
 Why?
Myeloid-Derived Suppressor Cells
2
2018
76
0.250
 Why?
Estrogen Receptor alpha
3
2025
151
0.240
 Why?
Adaptation, Psychological
2
2022
715
0.230
 Why?
Time Factors
7
2020
7107
0.230
 Why?
Disease Management
3
2021
651
0.230
 Why?
Estrogen Receptor Antagonists
1
2025
4
0.230
 Why?
Reproductive History
2
2015
12
0.230
 Why?
CD8-Positive T-Lymphocytes
5
2023
917
0.220
 Why?
Ovarian Reserve
1
2025
18
0.220
 Why?
Germ-Line Mutation
1
2026
176
0.220
 Why?
Hematopoietic Stem Cell Transplantation
1
2011
698
0.220
 Why?
Primary Ovarian Insufficiency
1
2025
40
0.220
 Why?
Mammography
3
2025
166
0.220
 Why?
Macrophages
4
2018
1500
0.220
 Why?
Energy Intake
2
2025
507
0.220
 Why?
Dimethyl Sulfoxide
1
2005
42
0.220
 Why?
Cell Plasticity
1
2025
37
0.220
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2022
108
0.210
 Why?
Proportional Hazards Models
2
2022
1325
0.210
 Why?
Genetic Predisposition to Disease
6
2024
2351
0.210
 Why?
Transforming Growth Factor beta1
1
2025
176
0.210
 Why?
Spectrometry, Mass, Electrospray Ionization
1
2005
174
0.210
 Why?
Adolescent
20
2024
22479
0.210
 Why?
Bupropion
1
2004
48
0.200
 Why?
Disease Progression
10
2020
2857
0.200
 Why?
Reproductive Techniques, Assisted
1
2024
47
0.200
 Why?
Lymph Nodes
3
2019
502
0.200
 Why?
Treatment Outcome
10
2026
11741
0.200
 Why?
Drug Administration Schedule
3
2018
781
0.200
 Why?
Tumor Microenvironment
7
2026
733
0.200
 Why?
Diarrhea
3
2019
193
0.190
 Why?
Immunotherapy
3
2025
665
0.190
 Why?
Cell Proliferation
5
2021
2504
0.190
 Why?
Disease Models, Animal
5
2020
4552
0.190
 Why?
Liver
3
2020
1893
0.190
 Why?
Pharmaceutical Preparations
1
2005
170
0.190
 Why?
Multiple Sclerosis
1
2008
487
0.190
 Why?
Age Factors
9
2021
3338
0.190
 Why?
Hypertension, Pregnancy-Induced
1
2023
69
0.190
 Why?
Aurora Kinase A
2
2019
61
0.180
 Why?
Women's Health
1
2024
314
0.180
 Why?
Chromatography, Liquid
1
2004
450
0.180
 Why?
Pilonidal Sinus
1
2001
4
0.180
 Why?
Antineoplastic Agents, Immunological
3
2019
198
0.180
 Why?
Genomic Instability
1
2022
67
0.180
 Why?
Condylomata Acuminata
1
2001
7
0.180
 Why?
Retrospective Studies
11
2026
17247
0.180
 Why?
Proteomics
2
2020
1185
0.170
 Why?
Drug Monitoring
2
2019
399
0.170
 Why?
Hematopoiesis
1
2022
193
0.170
 Why?
Nausea
2
2018
112
0.170
 Why?
Artificial Intelligence
1
2026
381
0.170
 Why?
Aged, 80 and over
7
2025
8318
0.170
 Why?
Genetic Testing
3
2026
480
0.170
 Why?
Piperazines
1
2023
375
0.170
 Why?
Ki-67 Antigen
2
2019
117
0.160
 Why?
Mass Spectrometry
1
2004
728
0.160
 Why?
Dyspareunia
1
2020
8
0.160
 Why?
Mice, Inbred BALB C
6
2019
1261
0.160
 Why?
Body Image
3
2020
95
0.160
 Why?
Cancer Care Facilities
1
2020
48
0.160
 Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.160
 Why?
Biopsy
4
2018
1079
0.160
 Why?
Ibuprofen
2
2018
86
0.160
 Why?
Risk
3
2013
916
0.150
 Why?
Neoplasm Grading
5
2021
310
0.150
 Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1188
0.150
 Why?
Mice, Inbred NOD
1
2021
613
0.150
 Why?
p21-Activated Kinases
1
2019
13
0.150
 Why?
Bone Neoplasms
2
2016
255
0.150
 Why?
Benzodiazepines
1
2021
168
0.150
 Why?
Sexual Health
1
2020
68
0.150
 Why?
Fatigue
2
2018
363
0.150
 Why?
Pregnancy Outcome
4
2026
500
0.150
 Why?
Cell Adhesion
1
2020
451
0.150
 Why?
Immunohistochemistry
8
2019
1713
0.150
 Why?
Parkinson Disease
2
2015
599
0.140
 Why?
Sexual Dysfunctions, Psychological
1
2019
30
0.140
 Why?
Carcinoma, Ductal
2
2011
10
0.140
 Why?
Receptor, trkB
1
2019
39
0.140
 Why?
Germ Cells
3
2024
65
0.140
 Why?
Lymphangiogenesis
2
2018
27
0.140
 Why?
Response Evaluation Criteria in Solid Tumors
1
2018
21
0.140
 Why?
Cell Communication
1
2020
328
0.140
 Why?
Stress, Psychological
2
2025
1145
0.140
 Why?
Pyrazoles
3
2018
517
0.140
 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2018
14
0.140
 Why?
Tryptophan Oxygenase
1
2018
33
0.140
 Why?
Progesterone
2
2025
214
0.140
 Why?
Ipilimumab
1
2018
40
0.140
 Why?
Neoplasm Proteins
2
2020
441
0.140
 Why?
Sexual Dysfunction, Physiological
1
2019
75
0.140
 Why?
Parenting
1
2022
319
0.130
 Why?
Cisplatin
1
2020
344
0.130
 Why?
Brain-Derived Neurotrophic Factor
1
2019
153
0.130
 Why?
Vitamin D
1
2021
403
0.130
 Why?
Area Under Curve
1
2018
329
0.130
 Why?
Cross-Sectional Studies
7
2025
5886
0.130
 Why?
United States
8
2025
16065
0.130
 Why?
Tretinoin
1
2018
125
0.130
 Why?
Receptors, Antigen, T-Cell
2
2023
673
0.130
 Why?
T-Lymphocytes, Regulatory
2
2018
407
0.130
 Why?
Immunity, Mucosal
1
2018
98
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.130
 Why?
Patient Care Management
1
2017
56
0.130
 Why?
Tryptophan
1
2018
182
0.130
 Why?
Granulocytes
1
2017
81
0.120
 Why?
Socioeconomic Factors
5
2021
1321
0.120
 Why?
Case-Control Studies
3
2020
3616
0.120
 Why?
Drug Delivery Systems
2
2010
380
0.120
 Why?
Global Health
1
2020
403
0.120
 Why?
Carcinoma, Squamous Cell
1
2001
640
0.120
 Why?
Protein-Tyrosine Kinases
1
2019
431
0.120
 Why?
Metaplasia
1
2016
57
0.120
 Why?
Pancreatic Cyst
1
2017
50
0.120
 Why?
Cell Transformation, Neoplastic
3
2015
337
0.120
 Why?
Radiotherapy, Image-Guided
1
2016
39
0.120
 Why?
Surveys and Questionnaires
8
2024
6055
0.120
 Why?
Prostatic Neoplasms
2
2021
978
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
 Why?
Dyskinesia, Drug-Induced
1
1995
14
0.120
 Why?
Cellular Microenvironment
1
2016
93
0.120
 Why?
Levodopa
1
1995
40
0.110
 Why?
Epithelium
2
2015
310
0.110
 Why?
Antiparkinson Agents
1
1995
41
0.110
 Why?
Depression
3
2020
1537
0.110
 Why?
Cytophagocytosis
1
2015
5
0.110
 Why?
Prophylactic Surgical Procedures
1
2015
7
0.110
 Why?
Adherens Junctions
1
2015
24
0.110
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
343
0.110
 Why?
Transforming Growth Factor beta3
1
2015
15
0.110
 Why?
Lung Neoplasms
2
2021
2662
0.110
 Why?
Paracrine Communication
1
2015
67
0.110
 Why?
Phosphoproteins
2
2015
337
0.110
 Why?
Menarche
1
2015
52
0.110
 Why?
Rats
6
2021
5582
0.110
 Why?
Chronic Pain
1
2019
289
0.110
 Why?
Lymphocyte Activation
3
2017
1131
0.110
 Why?
Risk Reduction Behavior
1
2016
217
0.110
 Why?
Lymph Node Excision
2
2021
173
0.110
 Why?
Microfilament Proteins
1
2015
135
0.110
 Why?
Spleen
1
2017
507
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Pyrimidines
1
2018
530
0.110
 Why?
Survival Analysis
4
2021
1371
0.110
 Why?
Gastrointestinal Microbiome
1
2022
766
0.110
 Why?
Survivors
3
2023
522
0.100
 Why?
Aging
1
2025
1962
0.100
 Why?
Peptide YY
2
2025
28
0.100
 Why?
Amenorrhea
1
2014
31
0.100
 Why?
Mammary Neoplasms, Animal
1
2014
34
0.100
 Why?
Extracellular Matrix
2
2016
561
0.100
 Why?
Odds Ratio
4
2020
1082
0.100
 Why?
Carbon Cycle
1
2014
13
0.100
 Why?
Administration, Oral
3
2025
862
0.100
 Why?
Ghrelin
2
2025
42
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Calcium-Binding Proteins
1
2015
221
0.100
 Why?
Multivariate Analysis
2
2019
1546
0.100
 Why?
Droughts
1
2014
30
0.100
 Why?
Monocytes
1
2017
537
0.100
 Why?
Collagen
2
2021
455
0.100
 Why?
Disability Evaluation
1
2015
310
0.100
 Why?
Atmosphere
1
2014
52
0.100
 Why?
Spouses
1
2015
108
0.100
 Why?
Tremor
1
1994
98
0.100
 Why?
Male
20
2022
72664
0.100
 Why?
Astrocytes
1
2015
228
0.100
 Why?
Neoplastic Cells, Circulating
2
2016
81
0.100
 Why?
Signal Transduction
4
2020
5208
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
977
0.100
 Why?
Antigens, Differentiation, Myelomonocytic
3
2019
66
0.100
 Why?
Nitriles
1
2014
207
0.090
 Why?
Trans-Activators
1
2015
396
0.090
 Why?
Infertility, Female
1
2014
121
0.090
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
27
0.090
 Why?
Lymphatic Vessels
3
2019
63
0.090
 Why?
Triazoles
1
2014
187
0.090
 Why?
Genome-Wide Association Study
1
2019
1376
0.090
 Why?
Myeloid Cells
1
2013
146
0.090
 Why?
Postural Balance
1
2015
244
0.090
 Why?
Apoptosis
3
2019
2434
0.090
 Why?
Drug Design
1
2013
175
0.090
 Why?
Live Birth
2
2023
77
0.090
 Why?
Analgesics, Opioid
1
2021
1145
0.090
 Why?
Cardiovascular Diseases
1
2024
2183
0.090
 Why?
Logistic Models
5
2016
2133
0.090
 Why?
Genes, Bacterial
1
2012
152
0.090
 Why?
Wound Healing
1
2014
354
0.090
 Why?
Interpersonal Relations
1
2015
397
0.090
 Why?
Fibrillar Collagens
1
2011
14
0.090
 Why?
Mice, Inbred C57BL
6
2019
5972
0.090
 Why?
Real-Time Polymerase Chain Reaction
1
2012
337
0.080
 Why?
Double-Blind Method
3
2021
2057
0.080
 Why?
Transcriptome
2
2021
1029
0.080
 Why?
Patient Participation
1
2015
437
0.080
 Why?
Antigen Presentation
2
2018
207
0.080
 Why?
Membrane Proteins
2
2015
1163
0.080
 Why?
B7-H1 Antigen
2
2026
243
0.080
 Why?
Biopsy, Needle
1
2011
185
0.080
 Why?
Streptococcus agalactiae
1
2012
110
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
932
0.080
 Why?
Estrogen Antagonists
1
2010
37
0.080
 Why?
Adenocarcinoma
2
2015
920
0.080
 Why?
Sexual Behavior
1
2014
494
0.080
 Why?
Cell Fusion
2
2006
48
0.080
 Why?
Pregnancy Trimester, Second
1
2009
83
0.070
 Why?
Radiotherapy, Adjuvant
2
2021
221
0.070
 Why?
Clinical Trials as Topic
3
2017
1058
0.070
 Why?
Sentinel Lymph Node Biopsy
3
2021
117
0.070
 Why?
Mucin-1
1
2009
21
0.070
 Why?
Reference Standards
2
2012
177
0.070
 Why?
Cell Movement
3
2019
959
0.070
 Why?
In Situ Hybridization, Fluorescence
3
2019
323
0.070
 Why?
Interferon beta-1a
1
2008
14
0.070
 Why?
Glatiramer Acetate
1
2008
18
0.070
 Why?
Pregnancy Trimester, First
1
2009
138
0.070
 Why?
Macrophage Activation
1
2010
181
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2020
50
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
187
0.070
 Why?
Rats, Sprague-Dawley
4
2016
2524
0.070
 Why?
Dose-Response Relationship, Drug
3
2018
2026
0.070
 Why?
Interferon-beta
1
2008
92
0.070
 Why?
Metalloproteases
1
2008
42
0.070
 Why?
Extracellular Matrix Proteins
1
2009
156
0.070
 Why?
Sensitivity and Specificity
3
2013
1995
0.070
 Why?
Gonadal Steroid Hormones
1
2009
143
0.070
 Why?
Phenotype
3
2026
3138
0.070
 Why?
Age of Onset
2
2021
554
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2009
376
0.060
 Why?
Cell Cycle
2
2021
596
0.060
 Why?
Genomics
2
2023
819
0.060
 Why?
Disease Susceptibility
1
2009
343
0.060
 Why?
Maximum Tolerated Dose
2
2018
210
0.060
 Why?
ErbB Receptors
3
2017
635
0.060
 Why?
Gene Knockdown Techniques
2
2020
333
0.060
 Why?
Mice, Nude
3
2015
679
0.060
 Why?
Sternum
1
2006
27
0.060
 Why?
Antibodies, Monoclonal
3
2009
1505
0.060
 Why?
Cell Survival
2
2020
1100
0.060
 Why?
Cells, Cultured
3
2019
4142
0.060
 Why?
Polymerase Chain Reaction
2
2016
1039
0.060
 Why?
Membrane Glycoproteins
2
2019
499
0.060
 Why?
Ovariectomy
2
2019
165
0.060
 Why?
Risk Assessment
3
2026
3740
0.060
 Why?
HIV Infections
1
2001
3186
0.060
 Why?
Postmenopause
2
2005
391
0.060
 Why?
Axilla
2
2021
51
0.060
 Why?
Keratins
1
2026
171
0.060
 Why?
Child
6
2022
22670
0.060
 Why?
Models, Biological
2
2012
1763
0.060
 Why?
Forkhead Transcription Factors
2
2018
207
0.060
 Why?
Prolactin
1
2025
87
0.060
 Why?
Mammaplasty
2
2021
141
0.060
 Why?
Fear
2
2021
367
0.060
 Why?
Anti-Mullerian Hormone
1
2025
60
0.050
 Why?
Mice, Knockout
2
2025
3114
0.050
 Why?
Thyrotropin
1
2025
120
0.050
 Why?
Infant, Newborn
2
2023
6435
0.050
 Why?
PTEN Phosphohydrolase
1
2026
165
0.050
 Why?
Dendritic Cells
2
2005
496
0.050
 Why?
Enzyme Inhibitors
1
2008
820
0.050
 Why?
Analysis of Variance
3
2014
1300
0.050
 Why?
Solubility
1
2005
240
0.050
 Why?
Congresses as Topic
1
2026
223
0.050
 Why?
Ovulation Induction
1
2024
63
0.050
 Why?
Neoplastic Processes
1
2023
5
0.050
 Why?
Follicle Stimulating Hormone
1
2025
262
0.050
 Why?
Cancer Vaccines
1
2005
161
0.050
 Why?
Weaning
2
2016
51
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2025
219
0.050
 Why?
North America
1
2024
301
0.050
 Why?
Cryopreservation
1
2024
113
0.050
 Why?
Celecoxib
2
2014
41
0.050
 Why?
Sensation
1
2022
55
0.050
 Why?
Withholding Treatment
1
2023
80
0.050
 Why?
DNA End-Joining Repair
1
2022
22
0.050
 Why?
Peptides
1
2008
997
0.050
 Why?
Mucins
1
2022
75
0.050
 Why?
Cost of Illness
1
2024
324
0.040
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
333
0.040
 Why?
Chromosome Aberrations
1
2022
165
0.040
 Why?
Colorado
3
2020
4538
0.040
 Why?
Psychiatric Status Rating Scales
2
2015
529
0.040
 Why?
Chemoradiotherapy, Adjuvant
1
2021
44
0.040
 Why?
Evidence-Based Medicine
1
2025
739
0.040
 Why?
Genes, p53
1
2021
67
0.040
 Why?
Multiple Myeloma
1
2005
309
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2021
116
0.040
 Why?
Placebos
1
2021
193
0.040
 Why?
Hypertrophy
1
2021
128
0.040
 Why?
Reproducibility of Results
2
2012
3410
0.040
 Why?
In Situ Hybridization
1
2001
318
0.040
 Why?
Protective Agents
1
2021
42
0.040
 Why?
Societies, Medical
1
2025
898
0.040
 Why?
Referral and Consultation
1
2007
862
0.040
 Why?
Immunity
1
2021
140
0.040
 Why?
Neoplasm, Residual
1
2021
143
0.040
 Why?
Hormones
1
2021
135
0.040
 Why?
DNA Replication
1
2022
249
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Early Detection of Cancer
1
2026
482
0.040
 Why?
CD4-Positive T-Lymphocytes
2
2019
1138
0.040
 Why?
Arm
1
2021
110
0.040
 Why?
Pregnancy Rate
1
2020
78
0.040
 Why?
Cross-Over Studies
1
2022
608
0.040
 Why?
Flow Cytometry
3
2013
1159
0.040
 Why?
DNA Repair
1
2022
254
0.040
 Why?
Morbidity
1
2021
322
0.040
 Why?
Consolidation Chemotherapy
1
2019
11
0.040
 Why?
Confidence Intervals
1
2020
330
0.040
 Why?
Multicenter Studies as Topic
1
2021
410
0.040
 Why?
Kidney Neoplasms
1
2004
412
0.040
 Why?
Age Distribution
1
2020
402
0.040
 Why?
SEER Program
1
2021
229
0.040
 Why?
Patient Reported Outcome Measures
1
2024
497
0.040
 Why?
DNA, Viral
1
2001
355
0.040
 Why?
Base Sequence
2
2016
2168
0.040
 Why?
Vaginal Diseases
1
2019
19
0.040
 Why?
Fibronectins
1
2020
136
0.040
 Why?
Unemployment
1
2019
41
0.040
 Why?
Severity of Illness Index
2
2019
2928
0.040
 Why?
Leuprolide
1
2019
21
0.040
 Why?
Terminology as Topic
1
2021
256
0.040
 Why?
Mammary Neoplasms, Experimental
1
2019
62
0.040
 Why?
Sulfonamides
2
2014
583
0.040
 Why?
Interleukin-10
2
2014
309
0.040
 Why?
Crosses, Genetic
1
2018
123
0.030
 Why?
Hot Flashes
1
2019
91
0.030
 Why?
Weight Gain
1
2022
561
0.030
 Why?
Maintenance Chemotherapy
1
2018
42
0.030
 Why?
Factor Analysis, Statistical
1
2019
290
0.030
 Why?
Integrins
1
2018
90
0.030
 Why?
Body Weight
1
2022
969
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2019
167
0.030
 Why?
Antimetabolites, Antineoplastic
1
2018
105
0.030
 Why?
Kynurenine
1
2018
114
0.030
 Why?
Contraceptives, Oral
1
2017
37
0.030
 Why?
RNA, Small Interfering
1
2020
634
0.030
 Why?
Behavior
1
2018
89
0.030
 Why?
Patient Satisfaction
1
2021
708
0.030
 Why?
Dietary Supplements
1
2021
582
0.030
 Why?
Educational Status
1
2019
465
0.030
 Why?
Tumor Escape
1
2017
49
0.030
 Why?
Weight Loss
1
2022
845
0.030
 Why?
Drug Therapy, Combination
1
2019
1043
0.030
 Why?
National Cancer Institute (U.S.)
1
2016
54
0.030
 Why?
Cell Count
1
2017
319
0.030
 Why?
Emulsions
1
2016
59
0.030
 Why?
Alleles
1
2019
888
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2024
890
0.030
 Why?
Immune Tolerance
1
2018
385
0.030
 Why?
Radiotherapy Dosage
1
2016
288
0.030
 Why?
Population Surveillance
1
2019
484
0.030
 Why?
Immunophenotyping
1
2017
318
0.030
 Why?
Antigens, Differentiation
1
2015
76
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2016
149
0.030
 Why?
Body Mass Index
2
2015
2437
0.030
 Why?
Directive Counseling
1
2015
44
0.030
 Why?
Hybrid Cells
2
2005
49
0.030
 Why?
Molecular Targeted Therapy
1
2018
438
0.030
 Why?
Reproduction
1
2016
208
0.030
 Why?
Biomarkers
2
2021
4282
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1742
0.030
 Why?
Amyloid Precursor Protein Secretases
1
2015
78
0.030
 Why?
Medicare
1
2021
902
0.030
 Why?
Medication Adherence
1
2019
540
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
261
0.030
 Why?
Posture
1
2015
197
0.030
 Why?
Tropical Climate
1
2014
15
0.030
 Why?
Genotype
1
2019
1844
0.030
 Why?
Cognition
1
2022
1262
0.030
 Why?
Biota
1
2014
29
0.030
 Why?
Leukocyte Common Antigens
1
2014
87
0.030
 Why?
Dinoprostone
1
2014
180
0.030
 Why?
Trees
1
2014
59
0.030
 Why?
Fresh Water
1
2014
53
0.030
 Why?
STAT5 Transcription Factor
1
2013
50
0.030
 Why?
Tumor Burden
1
2015
324
0.030
 Why?
Terminal Care
1
2018
283
0.030
 Why?
Rain
1
2014
39
0.020
 Why?
Biomass
1
2014
96
0.020
 Why?
Blood Cell Count
1
2013
55
0.020
 Why?
Carbon Monoxide
1
2014
82
0.020
 Why?
Brazil
1
2014
179
0.020
 Why?
Dermoscopy
1
2013
11
0.020
 Why?
Clinical Decision-Making
1
2017
362
0.020
 Why?
Immunoblotting
1
2014
295
0.020
 Why?
Massachusetts
1
2014
180
0.020
 Why?
Necrosis
1
2014
243
0.020
 Why?
Family Health
1
1994
190
0.020
 Why?
Oncogenes
1
2013
118
0.020
 Why?
Wnt Signaling Pathway
1
2015
211
0.020
 Why?
Photosynthesis
1
2014
98
0.020
 Why?
Lipopolysaccharide Receptors
1
2013
88
0.020
 Why?
Fires
1
2014
77
0.020
 Why?
beta Catenin
1
2015
254
0.020
 Why?
Child, Preschool
2
2021
11835
0.020
 Why?
Karyotyping
1
2012
105
0.020
 Why?
Magnetic Resonance Imaging
1
2025
3892
0.020
 Why?
Immune System
1
2014
177
0.020
 Why?
Adiposity
1
2017
532
0.020
 Why?
Gonadotropin-Releasing Hormone
1
2014
216
0.020
 Why?
Accidental Falls
1
2015
225
0.020
 Why?
Opioid-Related Disorders
1
2021
600
0.020
 Why?
Observer Variation
1
2013
356
0.020
 Why?
Endothelial Cells
1
2018
873
0.020
 Why?
Carbon Dioxide
1
2014
227
0.020
 Why?
Cell Division
1
2013
753
0.020
 Why?
Comorbidity
1
2017
1657
0.020
 Why?
Menopause
1
2015
326
0.020
 Why?
Carcinogenesis
1
2013
227
0.020
 Why?
Calibration
1
2012
151
0.020
 Why?
Recurrence
1
2015
1134
0.020
 Why?
Polymorphism, Single Nucleotide
1
2019
2136
0.020
 Why?
Interferon-gamma
2
2005
784
0.020
 Why?
Seasons
1
2014
538
0.020
 Why?
RNA, Bacterial
1
2012
182
0.020
 Why?
Tomography, X-Ray Computed
2
2015
2767
0.020
 Why?
Cell Differentiation
1
2018
2040
0.020
 Why?
Cell Line
1
2016
2821
0.020
 Why?
Genome, Human
1
2013
419
0.020
 Why?
Mice, SCID
1
2011
369
0.020
 Why?
Photochemotherapy
1
2010
39
0.020
 Why?
Self Report
1
2015
867
0.020
 Why?
Universities
1
2013
443
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2012
337
0.020
 Why?
Feasibility Studies
1
2014
1109
0.020
 Why?
Microscopy, Confocal
1
2010
318
0.020
 Why?
Hypertension
1
2018
1269
0.020
 Why?
Matrix Metalloproteinases
1
2010
95
0.020
 Why?
Survival Rate
1
2014
2087
0.020
 Why?
Keratin-19
1
2009
4
0.020
 Why?
Immunomagnetic Separation
1
2009
4
0.020
 Why?
Palliative Care
1
2018
1017
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
21
0.020
 Why?
Dose-Response Relationship, Immunologic
1
2009
76
0.020
 Why?
Diagnosis, Differential
1
2013
1506
0.020
 Why?
Blotting, Western
1
2011
1177
0.020
 Why?
Physician-Patient Relations
1
2014
587
0.020
 Why?
Vinblastine
1
2009
75
0.020
 Why?
Species Specificity
1
2010
545
0.020
 Why?
ADAM12 Protein
1
2008
4
0.020
 Why?
Flavonoids
1
2009
85
0.020
 Why?
Estrogen Receptor Modulators
1
2008
14
0.020
 Why?
Perilipin-1
1
2008
16
0.020
 Why?
S100 Proteins
1
2008
35
0.020
 Why?
Sex Factors
1
1994
2099
0.020
 Why?
ADAM Proteins
1
2008
64
0.020
 Why?
Androstadienes
1
2008
75
0.020
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
132
0.020
 Why?
Perimenopause
1
2008
69
0.020
 Why?
DNA Primers
1
2009
505
0.020
 Why?
Matrix Metalloproteinase 9
1
2008
130
0.020
 Why?
Radiotherapy
1
2008
204
0.020
 Why?
Prevalence
1
2014
2855
0.020
 Why?
Gene Expression
1
2012
1474
0.020
 Why?
Piperidines
1
2009
220
0.020
 Why?
Chi-Square Distribution
1
2008
527
0.020
 Why?
Cluster Analysis
1
2008
500
0.020
 Why?
Precancerous Conditions
1
2008
166
0.020
 Why?
Protein Structure, Tertiary
1
2009
855
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
749
0.010
 Why?
Pleural Effusion
1
2006
59
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2005
49
0.010
 Why?
Cytotoxicity Tests, Immunologic
1
2005
38
0.010
 Why?
Receptors, CCR7
1
2005
32
0.010
 Why?
Receptors, Chemokine
1
2005
48
0.010
 Why?
Antigens, CD34
1
2005
89
0.010
 Why?
Interleukin-12
1
2005
115
0.010
 Why?
Hemocyanins
1
2004
61
0.010
 Why?
Positron-Emission Tomography
1
2006
343
0.010
 Why?
Carrier Proteins
1
2008
728
0.010
 Why?
Coculture Techniques
1
2004
247
0.010
 Why?
Patient Care Planning
1
2005
170
0.010
 Why?
Cell Separation
1
2004
304
0.010
 Why?
Cell Nucleus
1
2006
587
0.010
 Why?
Tumor Cells, Cultured
1
2004
886
0.010
 Why?
Brain
1
2014
2934
0.010
 Why?
Paclitaxel
1
2003
256
0.010
 Why?
Pilot Projects
1
2003
1889
0.010
 Why?
Vaccination
1
2004
1423
0.010
 Why?
Borges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (593) concept(s)
_
Co-Authors Expand Description
See all (68) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)